ArticleCureus2025
A Rare Case of Warm Autoimmune Hemolytic Anemia With Intravascular Hemolysis: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This case report highlights a rare presentation of warm autoimmune hemolytic anemia (AIHA) with an atypical manifestation of intravascular hemolysis. The case underscores the diagnostic complexity and therapeutic challenges involved when AIHA presents with unusual features in the context of multiple underlying risk factors like infection, autoimmune markers, and occupational exposure. A 53-year-old male with a history of mining-related environmental exposure and a single previous episode of syncope presented to the emergency department with weakness, fatigue, and a syncopal event. Laboratory findings revealed severe anemia with hemoglobin of 4.4 g/dL, elevated lactate dehydrogenase, low serum haptoglobin, and positive direct antiglobulin test (DAT) for IgG, consistent with warm AIHA. Intravascular hemolysis was noted despite a negative DAT for complement C3 and normal complement levels. The patient was treated with high-dose corticosteroids and blood transfusions, resulting in stabilized hemoglobin levels and discharge in stable condition. Further outpatient follow-up was recommended to evaluate potential underlying autoimmune or neoplastic etiologies. This case highlights the importance of considering atypical mechanisms in warm AIHA presentations. Factors such as high antibody titers, IgG subclass variations, connective tissue disorders, infection, and potential neoplastic processes should be explored. This case contributes to the growing understanding of AIHA variants and underscores the need for individualized assessment in cases with complex presentations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.